CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients
NCT ID: NCT04734873
Last Updated: 2022-09-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
46 participants
INTERVENTIONAL
2021-02-25
2021-08-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care
NCT05195749
Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19
NCT04346628
Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19
NCT05365321
Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)
NCT04547140
A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
NCT04379492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPI-006 (2 mg/kg) Plus Standard of Care
Participants will receive a single dose of CPI-006 at 2 mg/kg up to a maximum dose of 200 mg intravenously on Day 1 plus standard of care.
CPI-006 2 mg/kg + SOC
IV CPI-006 2 mg/kg up to a maximum dose of 200 mg plus standard of care
CPI-006 (1 mg/kg) Plus Standard of Care
Participants will receive a single dose of CPI-006 at 1 mg/kg up to a maximum dose of 100 mg intravenously on Day 1 plus standard of care.
CPI-006 1 mg/kg + SOC
IV CPI-006 1 mg/kg up to a maximum dose of 100 mg plus standard of care
Placebo Plus Standard of Care
Participants will receive a single dose of placebo intravenously on Day 1 plus standard of care.
Placebo + SOC
IV placebo plus standard of care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CPI-006 2 mg/kg + SOC
IV CPI-006 2 mg/kg up to a maximum dose of 200 mg plus standard of care
CPI-006 1 mg/kg + SOC
IV CPI-006 1 mg/kg up to a maximum dose of 100 mg plus standard of care
Placebo + SOC
IV placebo plus standard of care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Covid-19 illness of any duration of symptoms
* Hospitalized for Covid-19 for ≤ 5 days with mild to moderate Covid-19 symptoms and meets criteria for either Category 4, Category 5, or Category 6 per 8-point ordinal scale
* Adequate organ function
* Participants of child-bearing age must agree to use adequate contraception for 6 weeks after study treatment administration
Exclusion Criteria
* History of severe chronic respiratory disease and requirement for long-term oxygen therapy
* Uncontrolled active systemic infection or hemodynamic instability requiring admission to an intensive care unit
* Malignant tumor receiving treatment, or other serious systemic diseases affecting life expectancy within 29 days of screening
* Receipt of cancer chemotherapy or immunomodulatory drugs during preceding 2 months (steroids for treatment of Covid-19 are acceptable)
* Convalescent plasma (CCP) or anti-SARS-CoV-2 monoclonal antibodies administered \<24 hours prior to randomization. Must have recovered from any adverse events related to CCP treatment. Received chloroquine or hydroxychloroquine within last 7 days or during the study
* Current participation in other clinical trials including extended access programs
* Active deep vein thrombosis or pulmonary embolism within last 6 months
* Anticipated discharge from hospital or transfer to another hospital which is not a study site within 48 hours of admission
* Active uncontrolled co-morbid disease that may interfere with study conduct or interpretation of findings
* Known to be positive for HIV or positive test for chronic HBV infection or positive test for hepatitis C antibody
* Pregnancy or breast feeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corvus Pharmaceuticals, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
S. Mahabhashyam, MD, MPH
Role: STUDY_CHAIR
Corvus Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sharp Chula Vista Medical Center
Chula Vista, California, United States
El Centro Regional Medical Center
El Centro, California, United States
Sharp Grossmont Hospital
La Mesa, California, United States
Torrance Memorial Medical Center
Torrance, California, United States
Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
Cambridge Medical Trials
Alexandria, Louisiana, United States
MedPharmics
Metairie, Louisiana, United States
Holy Cross Hospital
Silver Spring, Maryland, United States
Mayo Clinic - Rochester
Rochester, Minnesota, United States
Stony Brook University Medical Center
Stony Brook, New York, United States
Cape Fear Valley Medical Center
Fayetteville, North Carolina, United States
Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Temple University Hospital
Philadelphia, Pennsylvania, United States
Clinica Zabala
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Clínica Adventista Belgrano
Estomba, Buenos Aires, Argentina
Instituto Medico Platense
La Plata, Buenos Aires, Argentina
Clinica Independencia
Munro, Buenos Aires, Argentina
Instituto Médico Río Cuarto
Río Cuarto, Córdoba Province, Argentina
Centro de Investigación Clínica - Clínica Viedma
Viedma, Río Negro Province, Argentina
Centro Médico IPAM
Rosario, Santa Fe Province, Argentina
Hospital Provincial Del Centenario
Rosario, Santa Fe Province, Argentina
Clinica Mayo de U.M.C.B. S.R.L
San Miguel de Tucumán, Tucumán Province, Argentina
Hospital de Clínicas Presidente Dr. Nicolás Avellaneda
San Miguel de Tucumán, Tucumán Province, Argentina
Fundación Sanatorio Güemes
Buenos Aires, , Argentina
Sanatorio Finochietto
Buenos Aires, , Argentina
Hospital Rawson
Córdoba, , Argentina
Hospital Vera Cruz
Belo Horizonte, Minas Gerais, Brazil
Hospital Agamenon Magalhães
Recife, Pernambuco, Brazil
Santa Casa de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Dia do Pulmão
Blumenau, Santa Catarina, Brazil
Clínica Supera
Chapecó, Santa Catarina, Brazil
Centro Hospitalar Nossa Saúde
Curitiba, , Brazil
Universidade Municipal São Caetano do Sul
São Caetano do Sul, , Brazil
Conjunto Hospitalar do Mandaqui
São Paulo, , Brazil
Hospital Anchieta
São Paulo, , Brazil
Hospital de Base Da Faculdade de Medicina de São José Do Rio Preto
São Paulo, , Brazil
Hospital E Maternidade Celso Pierro PUCCAMP
São Paulo, , Brazil
Universidade Federal Do Espirito Santo - Hospital Universitário Cassiano Antônio de Moraes - HUCAM
Vitória, , Brazil
Toronto General Hospital
Toronto, Ontario, Canada
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Hospital Base de Osorno
Concepción, , Chile
Clinica Vespucio
La Florida, , Chile
Research Network Consulting
Linares, , Chile
Clínica Dávila Y Servicios Médicos SA
Santiago, , Chile
Rodrigo Botero S.A.S
Medellín, Antioquia, Colombia
Fundacion Santa Fe de Bogota
Bogotá, Cundinamarca, Colombia
Clínica Universidad De la Sabana
Chía, Cundinamarca, Colombia
Fundacion Centro de Excelencia en Enfermedades Cronicas No Transmisibles
Montería, Departamento de Córdoba, Colombia
Clínica de la Mujer S.A.S.
Bogotá, , Colombia
Hospital Universitario Clinica San Rafael
Bogotá, , Colombia
Fundacion Hospitalaria San Vicente de Paul
Medellín, , Colombia
Promotora Medica Las Américas S.A- Clínica Las Américas
Medellín, , Colombia
Fundación Valle Del Lili
Santiago de Cali, , Colombia
Medizinische Hochschule Hannover
Hanover, Lower Saxony, Germany
Azienda Ospedaliera Cotugno
Napoli, Campania, Italy
ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco
Milan, Lombardy, Italy
ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda Ca' Granda
Milan, Lombardy, Italy
ASST Santi Paolo e Carlo - Azienda Universitaria-Polo Universitario San Paolo
Milan, Lombardy, Italy
Ospedale San Raffaele S.r.l.
Milan, Lombardy, Italy
ASST di Monza - Azienda Ospedaliera San Gerardo
Monza, Lombardy, Italy
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Lombardy, Italy
ASST della Valle Olona - Azienda Ospedaliera Ospedale Di Circolo Di Busto Arsizio
Busto Arsizio, , Italy
Hospital Civil Fray Antonio Alcalde
Guadalajara, Jalisco, Mexico
Hospital Universitario Dr. Jose Eleuterio González
Monterrey, Nuevo León, Mexico
Hospital Civil de Culiacán
Culiacán, Sinaloa, Mexico
Hospital General de Culiacán
Culiacán, Sinaloa, Mexico
Hospital Nacional Sergio E. Bernales
Comas, Lima region, Peru
Hospital Chancay y Servicios Basicos de Salud
Huaral, Lima region, Peru
Hospital Central Fuerza Aérea del Perú
Miraflores, Lima region, Peru
Hospital María Auxiliadora
San Juan de Miraflores, Lima region, Peru
Clínica Providencia
San Miguel, Lima region, Peru
Clínica San Pablo
Santiago de Surco, Lima region, Peru
Hospital Alberto Sabogal Sologuren
Callao, , Peru
Hospital Nacional Adolfo Guevara Velasco Essalud
Cusco, , Peru
Hospital Militar Central
Lima, , Peru
Hospital Nacional Guillermo Almenara Irigoyen
Lima, , Peru
Hospital Costa del Sol
Marbella, Málaga, Spain
Complejo Hospitalario de Navarra
Pamplona, Navarre, Spain
Hospital del Mar
Barcelona, , Spain
Hospital General Universitario de Guadalajara
Guadalajara, , Spain
Complejo Asistencial Universitario de Salamanca - H. Clinico
Salamanca, , Spain
Hospital Universitario A Coruña
Santiago de Compostela, , Spain
Municipal Institution City Clinical Hospital #6 of Dnipropetrovsk Regional Council
Dnipro, Dnipropetrovsk Oblast, Ukraine
Kharkiv Regional Clinical Infectious Diseases Hospital
Kharkiv, Kharkivs’ka Oblast’, Ukraine
Poltava Regional Clinical Infectious Hospital
Poltava, Poltava Oblast, Ukraine
Communal Non-Commercial Enterprise Vinnytsia City Clinical Hospital 1
Vinnytsia, Vinnytsia Oblast, Ukraine
Municipal enterprise Volyn Regional Clinical Hospital of Volyn Regional Council
Lutsk, Volyn Oblast, Ukraine
MNPE City Hospital No. 6 of Zaporizhzhia City Council
Zaporizhzhia, Zaporizhzhia Oblast, Ukraine
Municipal Institution City Hospital #7
Zhaporizhzhya, Zaporizhzhia Oblast, Ukraine
CNPE City Clinical Hospital #3 of Chernivtsi City Council
Chernivtsi, , Ukraine
Municipal Non-profit Enterprise "City Clinical Hospital # 4" of Dnipro City Council
Dnipro, , Ukraine
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPI-006-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.